Ginkgo Biloba Prevention Trial in Older Individuals
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This study will determine the effect of 240mg/day Ginkgo biloba in decreasing the incidence
of dementia and specifically Alzheimer's disease (AD), slowing cognitive decline and
functional disability, reducing incidence of cardiovascular disease, and decreasing total
mortality.
Phase:
Phase 3
Details
Lead Sponsor:
National Center for Complementary and Integrative Health (NCCIH)
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI) National Institute of Neurological Disorders and Stroke (NINDS) National Institute on Aging (NIA) Office of Dietary Supplements (ODS)